In Vitro–Derived Human Gametes as a Reproductive Technology: Scientific, Ethical, and Regulatory Implications: Proceedings of a Workshop (2023)

Chapter: Appendix B: Workshop Task and Agenda

Visit NAP.edu/10766 to get more information about this book, to buy it in print, or to download it as a free PDF.
Previous Chapter: Appendix A: References
Page 123 Cite
Suggested Citation: "Appendix B: Workshop Task and Agenda." National Academies of Sciences, Engineering, and Medicine. 2023. In Vitro–Derived Human Gametes as a Reproductive Technology: Scientific, Ethical, and Regulatory Implications: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/27259.
Save
Cancel

Appendix B

Workshop Task and Agenda

WORKSHOP TASK

A planning committee of the National Academies of Sciences, Engineering, and Medicine will convene a public workshop exploring scientific, ethical, and regulatory implications associated with the research and development of in vitro–derived human gametes. Potential topics will explore

  1. The current state of the science for in vitro derivation of male and female gametes from embryonic or induced pluripotent stem cells, including achievements with other mammalian species, roadblocks that remain to producing human gametes, and near-term prospects for overcoming remaining scientific and technical barriers.
  2. The extent to which in vitro–derived human gametes could offer new options or potentially address unmet needs for both laboratory research and for reproductive medicine.
  3. The ethical or social issues that would be raised by development or potential use of in vitro–derived human gametes.
  4. How research and potential reproductive use of in vitro–derived human gametes would be addressed by current regulation and whether existing regulatory approaches address the issues discussed during the workshop.

The public workshop will feature invited presentations and discussions. The planning committee will organize the workshop, select and invite

Page 124 Cite
Suggested Citation: "Appendix B: Workshop Task and Agenda." National Academies of Sciences, Engineering, and Medicine. 2023. In Vitro–Derived Human Gametes as a Reproductive Technology: Scientific, Ethical, and Regulatory Implications: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/27259.
Save
Cancel

speakers and discussants, and moderate the discussions. A workshop proceedings will be prepared by a designated rapporteur based on the information gathered and discussions held during the workshop, in accordance with National Academies policies and procedures.

WORKSHOP AGENDA

APRIL 19, 2023

Session 1: Opening Session

Objectives
  1. Introduce the workshop topic and rationale.
  2. Understand how research advances with induced pluripotent stem cells (iPSCs) are driving innovation in reproductive medicine.
  3. Highlight perspectives on the potential impact of IVG on different communities and affected stakeholders.
9:15am Welcome and Introduction
Eli Y. Adashi (Brown University) Workshop Chair (virtual)
9:30am Current State of the Science for Early Human Stem Cell Transitions
Ali Brivanlou (Rockefeller University) (virtual)
9:50am Discussion
10:00am Needs and Concerns in Human Biology and Reproductive Medicine
Session Introduction
Susan Crockin (O’Neill Institute, Georgetown Law) Moderator
10:05am Potential Impacts for Stakeholders and Society
Joel Michael Reynolds (Georgetown University)
Andrea Braverman (Thomas Jefferson University) (virtual)
Katherine Kraschel (Yale Law School)
10:30am Discussion
10:50am Break
Page 125 Cite
Suggested Citation: "Appendix B: Workshop Task and Agenda." National Academies of Sciences, Engineering, and Medicine. 2023. In Vitro–Derived Human Gametes as a Reproductive Technology: Scientific, Ethical, and Regulatory Implications: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/27259.
Save
Cancel

Session 2: State of the Science

Objectives
  1. Provide a high-level overview of human germ cell development.
  2. Present the current state of science for IVG, including research achievements with other mammalian species and roadblocks for achieving in vitro derivation of human gametes.
  3. Highlight near-term prospects for overcoming remaining scientific and technical barriers.

Session 2a: Context and Background

11:10am Session Introduction
Amander Clark (University of California, Los Angeles) and
Kotaro Sasaki (University of Pennsylvania) Moderators
11:15am Human Germ Cell Development
Azim Surani (Cambridge University and The Gurdon Institute) (virtual)
11:30am Discussion

Session 2b: The Oogenesis Pathway

11:40am Stem Cell–Derived Ovarian Germ Cells: The Rodent Paradigm
Katsuhiko Hayashi (Kyushu University, Japan)
11:55am Stem Cell–Derived Ovarian Germ Cells: The Primate and Human Paradigm
Mitinori Saitou (Kyoto University, Japan) (virtual)
12:10pm The Importance of Meiosis
Paula Cohen (Cornell University)
12:25pm Discussion
12:50pm Lunch
Page 126 Cite
Suggested Citation: "Appendix B: Workshop Task and Agenda." National Academies of Sciences, Engineering, and Medicine. 2023. In Vitro–Derived Human Gametes as a Reproductive Technology: Scientific, Ethical, and Regulatory Implications: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/27259.
Save
Cancel

Session 2c: The Spermatogenesis Pathway

1:50pm Stem Cell–Derived Testicular Germ Cells: The Primate and Human Paradigm
Kotaro Sasaki (University of Pennsylvania) Moderator
2:05pm Spermatogonial Stem Cell Transplantation
Kyle Orwig (University of Pittsburgh Medical Center)
2:20pm The Importance of Epigenetic Resetting in Germ Cells
Petra Hajkova (Imperial College, London)
2:35pm Germline Mutation and Variation: Considerations for IVG
Anne Goriely (Oxford University)
2:50pm Discussion
3:15pm Break

Session 3: Implications of IVG If It Were in Clinical Practice

Objectives
  1. Explore how IVG technology could potentially impact fertility care.
  2. Examine how IVG technology could intersect with currently available methods of assisted reproductive technology.
  3. Highlight how IVG’s potential path to clinical practice may differ between countries according to political, cultural, and religious contexts.
3:35pm Session Introduction
Hugh Taylor (Yale University) Moderator
3:40pm Clinical Considerations
Gamal Serour (Al Azhar University, Egypt) (virtual)
Paula Amato (Oregon Health and Sciences University)
4:20pm Discussion
4:50pm Concluding Remarks from Day 1
Susan Crockin (O’Neill Institute, Georgetown Law)
Page 127 Cite
Suggested Citation: "Appendix B: Workshop Task and Agenda." National Academies of Sciences, Engineering, and Medicine. 2023. In Vitro–Derived Human Gametes as a Reproductive Technology: Scientific, Ethical, and Regulatory Implications: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/27259.
Save
Cancel
5:00-6:30pm Reception (National Academies’ Keck Center Atrium, Washington, DC)

APRIL 20, 2023

9:30am Welcome and Orientation to Day 2
Hugh Taylor (Yale University)

Session 4: Social, Ethical, and Legal Considerations Raised by IVG

Objectives
  1. Frame key social, ethical, and legal questions that arise when considering IVG as a potential clinical tool.
  2. Discuss issues relating to informed consent, governance, egg donation, surrogacy, and the financialization of third-party reproduction.
  3. Consider how attitudes about IVG reflect societal values about genetically related progeny, parenting, and family building.
9:40am Session Introduction
Glenn Cohen (Harvard Law School) Moderator
9:45am Opening Perspectives
Michele Goodwin (University of California, Irvine) (virtual)
Alana Cattapan (University of Waterloo, Canada)
Sonia Suter (George Washington University)
Henry (Hank) Greely (Stanford University)
10:20am Discussion
11:00am Break

Session 5: Equity, Access, and Cost Considerations Associated with IVG

Objectives
  1. Explore how socioeconomic and equity considerations impact who would be able to access IVG as a new and disruptive technology.
  2. Contemplate lessons from existing practices in third-party reproduction to inform an understanding of how IVG would affect the global fertility industry.
Page 128 Cite
Suggested Citation: "Appendix B: Workshop Task and Agenda." National Academies of Sciences, Engineering, and Medicine. 2023. In Vitro–Derived Human Gametes as a Reproductive Technology: Scientific, Ethical, and Regulatory Implications: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/27259.
Save
Cancel
  1. Reflect on how funding sources in public vs. private health care systems impact patient access to reproductive medicine.
11:20am Session Introduction
Ubaka Ogbogu (University of Alberta, Canada) Moderator
11:25am Opening Perspectives
Lisa Ikemoto (University of California, Davis School of Law)
Amrita Pande (University of Cape Town, South Africa)
Lorian Hardcastle (University of Calgary) (virtual)
11:50am Discussion
12:30pm Lunch

Session 6: Imagining a Potential Clinical Research Pathway for Human IVG

Objectives
  1. Outline the major scientific and ethical elements that would need to be addressed to move from the laboratory to a clinical trial.
  2. Present regulatory frameworks that could apply to IVG.
  3. Discuss lessons learned from other pluripotent stem cell therapies that have successfully moved into clinical trials.
1:30pm Session Introduction
Jeffrey Kahn (Johns Hopkins University), Moderator
1:35pm U.S. Policy and Legal Approaches
Alta Charo (University of Wisconsin-Madison) (virtual)
1:45pm An Industry Perspective on the Potential Path to Clinical Research
Matthew Krisiloff (Conception Bio, Inc.)
1:55pm U.S. Regulatory Frameworks for a Translational Pathway from Lab to Clinical Trials for IVG
Peter Marks (U.S. Food and Drug Administration)
2:15pm Discussion
Page 129 Cite
Suggested Citation: "Appendix B: Workshop Task and Agenda." National Academies of Sciences, Engineering, and Medicine. 2023. In Vitro–Derived Human Gametes as a Reproductive Technology: Scientific, Ethical, and Regulatory Implications: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/27259.
Save
Cancel

Session 7: Breakout Group Discussions

2:45pm Orientation to Breakout Groups
NASEM staff, Moderators
3:00pm Break and Move to Groups
3:20pm Three Parallel Breakout Groups with Discussion Questions
Keck 100 BREAKOUT 1: Societal, Ethical, and Legal Implications of IVG
In anticipation of continued research progress, the ramifications of IVG must be proactively considered. The group will discuss the societal, ethical, and legal issues raised by its potential development and use.
Keck 101 BREAKOUT 2: Impact of IVG on the Fertility Enterprise
Fertility care has become a major business enterprise worldwide. The breakout group will discuss the potential impacts of IVG on this burgeoning industry should it ever be used clinically.
Keck 103 BREAKOUT 3: Translating IVG from Laboratory to Market
Emerging technologies require extensive testing and approvals before clinical use. The breakout group will discuss pathways for IVG from laboratory to any potential clinical use, including validation assays and regulatory considerations.
4:35pm Break and Reconvene in Keck 100
4:40pm Concluding Remarks from Day 2
Ubaka Ogbogu (University of Alberta, Canada)
4:50pm Adjourn Day 2
5:00-6:30pm Reception
National Academies’ Keck Center Atrium, Washington, DC
Page 130 Cite
Suggested Citation: "Appendix B: Workshop Task and Agenda." National Academies of Sciences, Engineering, and Medicine. 2023. In Vitro–Derived Human Gametes as a Reproductive Technology: Scientific, Ethical, and Regulatory Implications: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/27259.
Save
Cancel

APRIL 21, 2023

9:30am Welcome and Orientation to Day 3
Glenn Cohen (Harvard Law School)

Session 8: Breakout Group Report-Outs

9:45am Group 1 Report-Out and Discussion
Katherine Kraschel (Yale Law School) (virtual)
10:10am Group 2 Report-Out and Discussion
Amrita Pande (University of Cape Town, South Africa)
10:35am Group 3 Report-Out and Discussion
Jeffrey Kahn (Johns Hopkins University)

Session 9: Participatory Public Engagement Around Reproductive Science Advances

Objectives
  1. Examine public attitudes, values, and perceptions around IVG.
  2. Discuss how communities with relevant lived experiences shape research agendas and ongoing technology development.
  3. Highlight best practices for effective and productive engagement between stakeholders in research, medicine, regulation, and patient advocacy.
11:00am Session Introduction
Melissa Simon (Northwestern University) Moderator (virtual)
11:05am Opening Perspectives
Erica Marsh (University of Michigan)
Hannah Landecker (University of California, Los Angeles)
Tanika Gray Valbrun (The White Dress Project)
11:30am Discussion
12:10pm Lunch
Page 131 Cite
Suggested Citation: "Appendix B: Workshop Task and Agenda." National Academies of Sciences, Engineering, and Medicine. 2023. In Vitro–Derived Human Gametes as a Reproductive Technology: Scientific, Ethical, and Regulatory Implications: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/27259.
Save
Cancel

Session 10: Concluding Thoughts

1:00pm Key Messages from the Workshop
Amander Clark (University of California, Los Angeles)
2:10pm Next Steps
NASEM staff
2:30pm Adjourn Workshop
Eli Y. Adashi (Brown University) Workshop Chair
Page 132 Cite
Suggested Citation: "Appendix B: Workshop Task and Agenda." National Academies of Sciences, Engineering, and Medicine. 2023. In Vitro–Derived Human Gametes as a Reproductive Technology: Scientific, Ethical, and Regulatory Implications: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/27259.
Save
Cancel

This page intentionally left blank.

Page 123 Cite
Suggested Citation: "Appendix B: Workshop Task and Agenda." National Academies of Sciences, Engineering, and Medicine. 2023. In Vitro–Derived Human Gametes as a Reproductive Technology: Scientific, Ethical, and Regulatory Implications: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/27259.
Save
Cancel
Page 123
Page 124 Cite
Suggested Citation: "Appendix B: Workshop Task and Agenda." National Academies of Sciences, Engineering, and Medicine. 2023. In Vitro–Derived Human Gametes as a Reproductive Technology: Scientific, Ethical, and Regulatory Implications: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/27259.
Save
Cancel
Page 124
Page 125 Cite
Suggested Citation: "Appendix B: Workshop Task and Agenda." National Academies of Sciences, Engineering, and Medicine. 2023. In Vitro–Derived Human Gametes as a Reproductive Technology: Scientific, Ethical, and Regulatory Implications: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/27259.
Save
Cancel
Page 125
Page 126 Cite
Suggested Citation: "Appendix B: Workshop Task and Agenda." National Academies of Sciences, Engineering, and Medicine. 2023. In Vitro–Derived Human Gametes as a Reproductive Technology: Scientific, Ethical, and Regulatory Implications: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/27259.
Save
Cancel
Page 126
Page 127 Cite
Suggested Citation: "Appendix B: Workshop Task and Agenda." National Academies of Sciences, Engineering, and Medicine. 2023. In Vitro–Derived Human Gametes as a Reproductive Technology: Scientific, Ethical, and Regulatory Implications: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/27259.
Save
Cancel
Page 127
Page 128 Cite
Suggested Citation: "Appendix B: Workshop Task and Agenda." National Academies of Sciences, Engineering, and Medicine. 2023. In Vitro–Derived Human Gametes as a Reproductive Technology: Scientific, Ethical, and Regulatory Implications: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/27259.
Save
Cancel
Page 128
Page 129 Cite
Suggested Citation: "Appendix B: Workshop Task and Agenda." National Academies of Sciences, Engineering, and Medicine. 2023. In Vitro–Derived Human Gametes as a Reproductive Technology: Scientific, Ethical, and Regulatory Implications: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/27259.
Save
Cancel
Page 129
Page 130 Cite
Suggested Citation: "Appendix B: Workshop Task and Agenda." National Academies of Sciences, Engineering, and Medicine. 2023. In Vitro–Derived Human Gametes as a Reproductive Technology: Scientific, Ethical, and Regulatory Implications: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/27259.
Save
Cancel
Page 130
Page 131 Cite
Suggested Citation: "Appendix B: Workshop Task and Agenda." National Academies of Sciences, Engineering, and Medicine. 2023. In Vitro–Derived Human Gametes as a Reproductive Technology: Scientific, Ethical, and Regulatory Implications: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/27259.
Save
Cancel
Page 131
Page 132 Cite
Suggested Citation: "Appendix B: Workshop Task and Agenda." National Academies of Sciences, Engineering, and Medicine. 2023. In Vitro–Derived Human Gametes as a Reproductive Technology: Scientific, Ethical, and Regulatory Implications: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/27259.
Save
Cancel
Page 132
Next Chapter: Appendix C: Biographies of Speakers and Planning Committee Members
Subscribe to Email from the National Academies
Keep up with all of the activities, publications, and events by subscribing to free updates by email.